Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenedrive Regulatory News (GDR)

Share Price Information for Genedrive (GDR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.70
Bid: 1.60
Ask: 1.80
Change: 0.00 (0.00%)
Spread: 0.20 (12.50%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1.625
GDR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

30 Apr 2010 09:42

RNS Number : 1189L
Epistem Holdings plc
30 April 2010
 

 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii

Epistem Holdings plc

 

 

 

 

 

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

X

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

Other (please specify):

3. Full name of person(s) subject to the notification obligation: iii

Octopus Investments Nominees Limited

4. Full name of shareholder(s)  (if different from 3.):iv

5. Date of the transaction and date on which the threshold is crossed or reached: v

16/04/10

6. Date on which issuer notified:

29/04/10

7. Threshold(s) that is/are crossed or reached: vi, vii

4%

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type of shares

if possible using the ISIN CODE

Situation previous to the triggering transaction

Resulting situation after the triggering transaction

Number of Shares

Number of Voting Rights

Number of shares

Number of voting rights

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

GB00B1VKB244

 

364300

 

364300

 

315000

 

315000

 

3.97%

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial instrument

Expiration date xiii

Exercise/ Conversion Period xiv

Number of voting rights that may be acquired if the instrument is exercised/ converted.

% of voting rights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financial instrument

Exercise price

Expiration date xvii

Exercise/ Conversion period xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 

 

 

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

315000

 

3.97%

 

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: xxi

 

N/A

Proxy Voting:

10. Name of the proxy holder:

N/A

11. Number of voting rights proxy holder will cease to hold:

N/A

12. Date on which proxy holder will cease to hold voting rights:

N/A

13. Additional information:

14. Contact name:

Russell Jarvis

15. Contact telephone number:

020 7710 8653

 

Note: Annex should only be submitted to the FSA not the issuer

Annex: Notification of major interests in share

A: Identity of the persons or legal entity subject to the notification obligation

Full name

(including legal form of legal entities)

 

Peter Orsi

Contact address

(registered office for legal entities)

 

8 Angel Court, London, EC2R 7HP

Phone number & email

 

020 7710 8653

Other useful information

(at least legal representative for legal persons)

 

B: Identity of the notifier, if applicable

Full name

 

Contact address

 

Phone number & email

 

Other useful information

(e.g. functional relationship with the person or legal entity subject to the notification obligation)

C: Additional information

For notes on how to complete form TR-1 please see the FSA website.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLUROWRRWASORR
Date   Source Headline
22nd Dec 20217:00 amRNSUK CTDA application for Genedrive® COV19-ID kit
20th Dec 20214:41 pmRNSSecond Price Monitoring Extn
20th Dec 20214:36 pmRNSPrice Monitoring Extension
20th Dec 20211:08 pmRNSDirector/PDMR Shareholding
20th Dec 20217:00 amRNSHolding(s) in Company
14th Dec 20212:06 pmRNSSecond Price Monitoring Extn
14th Dec 20212:00 pmRNSPrice Monitoring Extension
13th Dec 20214:41 pmRNSSecond Price Monitoring Extn
13th Dec 20214:35 pmRNSPrice Monitoring Extension
9th Dec 202111:06 amRNSSecond Price Monitoring Extn
9th Dec 202111:00 amRNSPrice Monitoring Extension
9th Dec 20219:05 amRNSSecond Price Monitoring Extn
9th Dec 20219:00 amRNSPrice Monitoring Extension
8th Dec 20214:40 pmRNSSecond Price Monitoring Extn
8th Dec 20214:35 pmRNSPrice Monitoring Extension
8th Dec 20212:05 pmRNSSecond Price Monitoring Extn
8th Dec 20212:00 pmRNSPrice Monitoring Extension
8th Dec 202112:31 pmRNSCE-IVD certification for Point-of-Care kit
7th Dec 20219:00 amRNSPrice Monitoring Extension
7th Dec 20217:00 amRNSHolding(s) in Company
6th Dec 20214:43 pmRNSAdditional Listing of Shares
6th Dec 20212:05 pmRNSSecond Price Monitoring Extn
6th Dec 20212:00 pmRNSPrice Monitoring Extension
2nd Dec 20219:44 amRNSGrant of options
2nd Dec 20219:05 amRNSSecond Price Monitoring Extn
2nd Dec 20219:00 amRNSPrice Monitoring Extension
30th Nov 202111:05 amRNSSecond Price Monitoring Extn
30th Nov 202111:00 amRNSPrice Monitoring Extension
29th Nov 20214:41 pmRNSSecond Price Monitoring Extn
29th Nov 20214:36 pmRNSPrice Monitoring Extension
29th Nov 20212:06 pmRNSSecond Price Monitoring Extn
29th Nov 20212:01 pmRNSPrice Monitoring Extension
29th Nov 202110:32 amRNSBlock listing Interim Review
29th Nov 20217:00 amRNSPOC kit submitted for CE-IVD certification
26th Nov 20214:41 pmRNSSecond Price Monitoring Extn
26th Nov 20214:36 pmRNSPrice Monitoring Extension
17th Nov 20217:00 amRNSAnnual Report and Accounts and notice of AGM
16th Nov 20217:00 amRNSDirectorate Change
9th Nov 20217:00 amRNSFinal Results
28th Oct 20213:40 pmRNSNotice of Results
11th Oct 20217:00 amRNSDirector's shareholding
30th Sep 20211:00 pmRNSResult of General Meeting
29th Sep 20217:00 amRNSResult of Open Offer
29th Sep 20217:00 amRNSNew Genedrive System receives CE-IVD marking
14th Sep 20217:00 amRNSPublication of Circular and Notice of GM
10th Sep 20215:03 pmRNSResult of Placing
10th Sep 20214:40 pmRNSSecond Price Monitoring Extn
10th Sep 20214:35 pmRNSPrice Monitoring Extension
10th Sep 20212:01 pmRNSProposed Placing and Open Offer
31st Aug 20217:00 amRNSNew Genedrive system readied for AIHL launch

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.